Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC
Authors
Faivre-Finn, CorinneSpigel, D
Senan, S
Langer, C
Raben, D
Perez, B
Ozguroglu, M
Daniel, D
Villegas, A
Vicente, D
Hui, R
Murakami, S
Paz-Ares, L
Poole, L
Wadsworth, C
Dennis, P
Antonia, S
Affiliation
Clinical Oncology, The University of Manchester and The Christie NHS Foundation Trust, Manchester, UKIssue Date
2018
Metadata
Show full item recordCitation
Faivre-Finn C, Spigel DR, Senan S, Langer CJ, Raben D, Perez B, et al. 1363O Efficacy and safety evaluation based on time from completion of radiotherapy to randomization with durvalumab or placebo in pts from PACIFIC. Ann Oncol. 2018;29(suppl_8):488.Journal
Annals of OncologyDOI
10.1093/annonc/mdy291Additional Links
https://dx.doi.org/10.1093/annonc/mdy291Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy291